Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-10

Clinical Trial Update: S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 study (S0530) evaluated the combination of cytarabine and clofarabine in patients with relapsed or refractory acute lymphoblastic leukemia. Results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYTARABINE (CYTARABINE)
  • Clofarabine (clofarabine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2012-07-10